These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 30047430)

  • 41. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
    van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
    Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic sclerosis: bilateral improvement of Raynaud's phenomenon with unilateral digital sympathectomy.
    Wasserman A; Brahn E
    Semin Arthritis Rheum; 2010 Oct; 40(2):137-46. PubMed ID: 19878974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis.
    Motegi SI; Uehara A; Yamada K; Sekiguchi A; Fujiwara C; Toki S; Date Y; Nakamura T; Ishikawa O
    Acta Derm Venereol; 2017 Jul; 97(7):843-850. PubMed ID: 28358168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MULTIPLE TELANGIECTASIA, RAYNAUD'S PHENOMENON, SCLERODACTYLY, AND SUBCUTANIOUS CALCINOSIS: A SYNDROME MIMICKING HEREDITARY HEMORRHAGIC TELANGIECTASIA.
    WINTERBAUER RH
    Bull Johns Hopkins Hosp; 1964 Jun; 114():361-83. PubMed ID: 14171636
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 2: treatment].
    Zuber JP; Chizzolini C; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2006 Apr; 2(62):1058, 1060-6. PubMed ID: 16711151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic options for digital ulcers in patients with systemic sclerosis.
    Chung L
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):460-5. PubMed ID: 17537038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Variability of the clinical picture and the classification of progressive systemic scleroderma].
    Giordano M; Ara M; Capelli L; Tirri G; Vatti M
    Z Rheumatol; 1976; 35(7-8):286-300. PubMed ID: 961080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of complications associated with systemic sclerosis.
    Moore SC; Desantis ER
    Am J Health Syst Pharm; 2008 Feb; 65(4):315-21. PubMed ID: 18238768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Raynaud phenomenon and ischemic ulcers associated to systemic sclerosis with hyperbaric oxygen.
    Ahijón-Lana M; Baragaño-Ordóñez E; Veiga-Cabello R; de la Cruz-Tapidor C; Carreira PE
    Reumatol Clin (Engl Ed); 2022 Apr; 18(4):246-248. PubMed ID: 34953734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.
    Valenzuela A; Baron M; ; Herrick AL; Proudman S; Stevens W; ; Rodriguez-Reyna TS; Vacca A; Medsger TA; Hinchcliff M; Hsu V; Wu JY; Fiorentino D; Chung L
    Semin Arthritis Rheum; 2016 Dec; 46(3):344-349. PubMed ID: 27371996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic sclerosis: Recent insights.
    Elhai M; Avouac J; Kahan A; Allanore Y
    Joint Bone Spine; 2015 May; 82(3):148-53. PubMed ID: 25557659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcinosis cutis of the fingertip associated with Raynaud's phenomenon.
    Yang JH; Kim JW; Park HS; Jang SJ; Choi JC
    J Dermatol; 2006 Dec; 33(12):884-6. PubMed ID: 17169096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis.
    Yamane K
    Intern Med; 1994 Oct; 33(10):579-82. PubMed ID: 7827371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Digital ulcers: overt vascular disease in systemic sclerosis.
    Steen V; Denton CP; Pope JE; Matucci-Cerinic M
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients.
    Daumas A; Magalon J; Jouve E; Truillet R; Casanova D; Giraudo L; Veran J; Benyamine A; Dignat-George F; Magalon G; Sabatier F; Granel B
    Curr Res Transl Med; 2017; 65(1):40-43. PubMed ID: 28340695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scleroderma in children.
    Uziel Y; Miller ML; Laxer RM
    Pediatr Clin North Am; 1995 Oct; 42(5):1171-203. PubMed ID: 7567191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
    Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.